HIV/AIDS News & Information

Crohn’s Disease with Fistula
Adalimumab (Humira, Abbott), a fully human monoclonal antibody that targets tumor necrosis factor (TNF), has been found efficacious for inducing and maintaining remission in patients with Crohn’s disease (CD). According to data presented at the meeting, adalimumab offers sustained responses for the 20% to 30% of patients whose course is complicated by [...]

When early reports of increased mortality rates caused the premature discontinuation of the European Organisation for Research and Treatment of Cancer trial (EORTC 18961) of a post-surgical vaccine for patients with node-negative malignant melanoma, it cast a pall over the vaccine horizon, noted Dr. Eggermont. At a Pfizer-sponsored satellite symposium on cytotoxic T-lymphocyte antigen-4 (CTLA-4) [...]

European Cancer Conference
The 14th meeting of the European CanCer Organisation (ECCO) took place in Barcelona, Spain, from September 23 to 27, 2007. Close to 14,000 attendees heard the latest scientific advances in cancer treatment. This article covers key sessions in breast cancer, prostate cancer, renal cancer, and melanoma.

This study identified predisposing and program intervention factors that influence African-American men’s participation in prostate cancer screening. The predisposing factors were labeled using the constructs of existing health behavior theories. The most important findings in this study were the personal statements of the participants which reflect their true feelings. A major predisposing factor identified in [...]

Study Participants
A total of 49 African-American men participated in the 10 focus group sessions. There were 21 participants in Tallahassee, 15 in Miami, and 13 in Tampa. The demographic information of the participants is summarized in Table 1. Only 24% of the participants had a college degree. The majority of the participants (41%) were married. [...]

This study was part of a Florida Prostate Cancer Project funded by the U.S. Army Department of Defense to develop a model explaining the behavior of African-American men relative to prostate cancer screening. A qualitative study was conducted to elicit factors perceived by African-American men as influencing their participation in prostate cancer screening. A total [...]

INTRODUCTION
The U.S. Healthy People 2010 goal for prostate cancer is to reduce prostate cancer death rate to 28.8 deaths per 100,000 males by 2010 (Objective 3-7 of the Healthy People 2010, second edition, 2000). The reported death rate for African-American men in 2000 was 66.9 per 100,000 males and for white men 27.7 per 100,000 [...]